Efficacy, safety and sample quality of ultrasound-guided synovial needle biopsy in clinical practice and research: a prospective observational study.
To study the efficacy, tolerability, safety and sampling variation of ultrasound (US)-guided synovial biopsies performed in clinical practice and research. We included all patients having an US-guided synovial needle biopsy from November 2013 to January 2018. Patients were evaluated for procedure safety and tolerability. Usefulness of synovial biopsy was considered based on contribution for achieving the proposed aims. We analyzed samples for presence and quality of synovial tissue, synovitis score/grade and pathotype. Variation across patients, samples, section levels and sampling order was assessed. Sixty-four US-guided synovial biopsies were performed (clinical practice n=52, research n=12). Patient tolerability (70% no/mild discomfort) was remarkably high. There was no significant aggravation of biopsied joint symptoms or US synovitis. Procedures were overall safe, with few minor, two moderate and no major adverse events. Usefulness of US-guided synovial biopsies was high, both in clinical practice (37% direct diagnostic impact, 100%/95% positive/negative predictive values for infection) and in research (92% success). Synovial tissue was retrieved in 88% of biopsies, with a median of 75% gradable samples. There was significant variation in sample quality and synovitis features across patients and samples, but not between different section levels. Samples collected later in the procedure had a lower frequency of synovial tissue and were poorly concordant in pathotype with those collected earlier. US-guided synovial needle biopsy is an effective, safe, well-tolerated mean to collect good quality synovial tissue for clinical and research purposes. Samples collected for different aims should be retrieved in parallel, rather than sequentially. This article is protected by copyright. All rights reserved.